Physician

Antony Leslie Innasimuthu, MD

According to 2025 Medicare claims, Antony Innasimuthu, MD (NPI: 1104080639) practices cardiology in the Wilmington, DE-MD-NJ market, with the plurality of this provider's patient population coming from New Castle, DE. This provider's primary affiliated billing organization is DELAWARE HEART AND VASCULAR GROUP LLC (NPI: 1053152652; TIN: 993147678) and primary practice location at 19810-9998. Innasimuthu is affiliated with the eBrightHealth ACO (ACO ID: A3053), participating under the MSSP model.

Innasimuthu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,683 traditional Medicare patients, billed 9,688 HCPCS/CPT codes, and received $553,880 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 4,762 prescription claims across 728 beneficiaries totaling $1,326,703 in drug costs, led by Eliquis (Apixaban). DME data shows 12 claims. Open Payments data shows 33 records totaling $705. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $90,383 to $1,326,703. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $20,605 to $2,661.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,225	6,053	$787,784
2016	1,819	8,304	$653,901
2017	1,722	8,325	$625,110
2018	1,612	6,997	$547,765
2019	1,346	6,612	$520,513
2020	1,562	7,253	$540,880
2021	1,519	9,889	$708,175
2022	1,574	11,441	$760,395
2023	1,527	9,574	$722,409
2024	1,683	9,688	$553,880

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	236	1,002	$90,383
2016	329	1,672	$170,800
2017	309	1,590	$191,128
2018	364	1,870	$236,357
2019	418	2,187	$306,769
2020	523	3,017	$469,826
2021	531	2,600	$511,758
2022	487	2,417	$539,852
2023	653	3,193	$810,272
2024	728	4,762	$1,326,703

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$20,605
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	19	$36,714
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	12	$845

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	313	318	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	634	1,101	$92
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	674	1,130	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	569	778	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	401	464	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	303	20,180	$380,209
Farxiga	Dapagliflozin Propanediol	239	15,910	$284,049
Xarelto	Rivaroxaban	181	13,440	$240,192
Jardiance	Empagliflozin	79	6,000	$113,243
Entresto	Sacubitril/Valsartan	66	3,905	$81,698

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$845

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	33	$705	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Antony Leslie Innasimuthu, MD?

Tedicare shows public-source Medicare data for Antony Leslie Innasimuthu, MD (NPI 1104080639), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Antony Leslie Innasimuthu, MD have ACO affiliation data?

Antony Leslie Innasimuthu, MD is shown with ACO affiliation data for eBrightHealth ACO (MSSP, ACO ID A3053).

What billing organization is linked to Antony Leslie Innasimuthu, MD?

Antony Leslie Innasimuthu, MD is linked to DELAWARE HEART AND VASCULAR GROUP LLC (billing NPI 1053152652) in the available physician profile data.

Does Antony Leslie Innasimuthu, MD have Open Payments data?

Antony Leslie Innasimuthu, MD has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.